The drug was initially developed by BioVex, Inc. under the name OncoVEX GM-CSF until it was acquired by Amgen in 2011.
It was acquired by Amgen in 2011. The drug was developed by BioVex, Inc. under the name OncoVEX GM-CSF.
The drug was developed by BioVex, Inc. under the name OncoVEX GM-CSF. It was acquired by Amgen in 2011.
The drug was developed by BioVex, Inc. under the name OncoVEX GM-CSF. It was acquired by Amgen in 2011.